The largest database of trusted experimental protocols

Integra

Manufactured by Roche
Sourced in United Kingdom

INTEGRA is a lab equipment product by Roche. It is a liquid handling system designed for automated pipetting and sample processing in a laboratory setting.

Automatically generated - may contain errors

6 protocols using integra

1

Serum CRP Level Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were taken in tubes containing the coagulation activator by a veterinarian,, on the same day as the milk sample collection. The serum was centrifuged and CRP level was analyzed using INTEGRA (Roche, Switzerland) apparatus.
+ Open protocol
+ Expand
2

Routine Serum Biomarker Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following parameters were measured routinely in serum during the patients outpatient ward visit: total, LDL and HDL cholesterol as well as triglycerides were measured by enzymatic colorimetric tests on a P800 analyzer (Modular, Roche Diagnostics), C-reactive protein (CRP) by immunoturbidimetry, glucose by an enzymatic UV test (P800 analyzer; Modular; Roche Diagnostics), serum and urine albumin by a nephelometric method (BN II; Siemens), and serum creatinine by the Jaffé method (kinetic colour assay) which was corrected for unspecific protein reactions by a factor of −26.5 μmol/L. HbA1c was measured using an immunoturbidimetric Latex-assay (Integra; Roche Diagnostics) and was standardized according to the DCCT/NGPS.
+ Open protocol
+ Expand
3

Serum Biomarker Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum samples were analyzed in the COBAS INTEGRA® equipment (Roche, Model 400 plus, Sant Cugat del Valles, Spain). Glucose test (GOD-POD enzymatic colorimetric method), triglycerides (GPO-PAP enzymatic colorimetric method), total cholesterol (CHOD-PAP enzymatic colorimetric method), HDL-C and LDL-C (direct method), VLDL-C (calculated from Triglycerides/5), total proteins (cupric ion colorimetric method), albumin (BCG colorimetric method), C-reactive protein (agglutination protein method), creatinine (Jaffé’s kinetic method), urea and blood urea nitrogen (BUN) (indophenol colorimetric method), ureic acid (uricase and peroxidase colorimetric method) were determined. All reactive equipment was purchased from Roche® (Roche® México, CDMX, Mexico) and procedures were performed in accordance with the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Bone Density Evaluation in Dialysis Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-body DXA was performed using a Hologic Discovery A(S/N87402) (software version 13.5.2.1; Hologic, Marlborough, MA, USA). BMD was expressed as g/cm2 and measured at the following sites: femoral neck, lumbar spine (L1–L4), arm, head, pelvis and total body. T- and Z-scores were obtained using the third National Health and Nutrition Examination Survey (NHANES III) reference population [22 (link)]. Osteopenia and osteoporosis were defined as a T-score <−1 and −2.5, respectively. BMD was assessed after starting dialysis and then according to the supervising clinician's discretion. Venous blood samples were measured using a standard multichannel biochemical analyzer (Roche Integra, Roche Diagnostics, Lewes, UK). Serum albumin was determined by the bromocresol green method. Intact parathyroid hormone (PTH) was measured using a two-site immunometric assay (Roche Diagnostics, Burgess Hill, Sussex, UK). Laboratory values were collected at the time of the initial DXA scan and then concomitantly with repeat BMD measurements.
+ Open protocol
+ Expand
5

Hemodialysis Hemodynamic and Biochemical Changes

Check if the same lab product or an alternative is used in the 5 most similar protocols
BP was measured in a standardized manner both immediately prior to and after the HD session in the non-fistula arm while in the sitting position with cuff size chosen according to patient’s arm size. BP was measured using the automated HD integrated monitors. Devices were regularly calibrated. Mean arterial pressure (MAP) was calculated as 1/3 * SBP + 2/3 * diastolic BP (DBP). SBP decrease was expressed in mmHg and defined as: pre-HD SBP–post-HD SBP. The decrease in SBP index was expressed as a percentage and defined as: (pre-HD SBP–post-HD SBP) / pre-HD SBP. DBP and MAP decrease as well as decrease in DBP and MAP index were defined similarly. Pre- and post-HD blood samples were measured using a standard multi-channel biochemical analyser (Roche Integra, Roche diagnostics, Lewes, UK) with an indirect ion-selective electrode technique for Na. Serum albumin was determined by the bromocresol green method. Total serum calcium was measured and ionized calcium calculated using the Mateu-de Antonio equation, derived from patients with kidney failure (0.815 × total calcium0.5)11 (link). Bioelectrical impedance analysis was performed prior to and 20–30 min after the HD session using multifrequency segmental InBody 720 Body Composition Analysis (Biospace, Seoul, South Korea), following a standardized protocol12 (link).
+ Open protocol
+ Expand
6

Automated Serum Calcium Estimation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum total calcium estimation was done on an automated analyzer, COBAS INTEGRA 400 Plus. Roche Integra auto analyzer (Roche Diagnostics India Pvt. Ltd., Mumbai, India). Calcium ions react with O-cresolphthelein under alkaline conditions to form a violet colored complex. The addition of 8-hydroxylquinoline prevents interference by magnesium and ferric ions. The color intensity of the complex formed was directly proportional to the calcium concentration. It was determined by measuring the increase in absorbance at 552 nm. The value was expressed in mg/dl.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!